Seprafilm
Payments companies reported to CMS as associated with Seprafilm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Seprafilm, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Seprafilm
These are the largest totals companies reported as associated with Seprafilm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Weiss | Fort Lauderdale, FL | Plastic and Reconstructive Surgery | $5,580.00 |
| Michael Stine | Tampa, FL | Obstetrics & Gynecology | $4,539.32 |
| Allen Chudzinski | Tampa, FL | Colon & Rectal Surgery | $3,799.73 |
| Benjamin Phillips | Philadelphia, PA | Colon & Rectal Surgery | $2,790.00 |
| Dan Ruiz | Homestead, FL | Surgery | $2,610.00 |
| Steven Wexner | Weston, FL | Colon & Rectal Surgery | $2,557.50 |
| Paul Kaminsky | Portland, OR | Colon & Rectal Surgery | $2,086.00 |
| Kaylen Silverberg | Austin, TX | Reproductive Endocrinology | $1,500.00 |
| Jennifer Silinsky | Metairie, LA | Colon & Rectal Surgery | $504.52 |
| Robert Amajoyi | Kansas City, MO | Colon & Rectal Surgery | $368.93 |
Prescribed Seprafilm?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.